Mainstreaming – method or madness?

GENTURIS_webinars_20230426 - MT - foto Marc Tischkowitz_cropped_400x400.jpgMarc Tischkowitz is a Professor of Medical Genetics and Honorary Consultant in the Department of Medical Genetics at Cambridge. Much of his research has been on the Fanconi Anemia genes and hereditary breast cancer predisposition, but his interests cover all areas of hereditary cancer and translating the recent advances in genomic technology into clinical practice.




GENTURIS_webinars_20230426 - JB - foto Judith Balmana_cropped_400x400.jpgJudith Balmaña is the Head of the Hereditary Cancer Genetics Group at Vall d’Hebron Institute of Oncology (VHIO) and professor at the Faculty of Medicine in the International University of Catalonia, and the hereditary cancer track coordinator of the Master in Genetic Counseling (UAB). In 2005, she was involved in establishing the Familial Cancer Program in the Medical Oncology Department at Hospital Vall d’Hebron (HVH). Since then, she has been leading this program and serving as an Attending Physician in the Breast Cancer Unit.



In this webinar, Marc Tischkowitz (UK) and Judith Balmaña (Spain) will compare and contrast their experiences of implementing mainstream genetic testing for common hereditary cancer types.